Phase I Trial [resa]
motexafin gadolinium [irda, orch, phsu]
Combination [qlco]
docetaxel [orch, phsu]
Cisplatin [inch, phsu]
treatment [ftcn]
Non-Small Cell Lung Cancer [neop]
Introduction [hlca]
motexafin gadolinium [irda, orch, phsu]
Novel [tmco]
antineoplastic drug [orch, phsu]
disrupt [qlco]
Cancer Cell [cell]
Antioxidant [phsu]
System [ftcn]
Contributing [acty]
Cellular [cell]
Patients [podg]
Lung Cancer [neop]
Neurologic [qlco]
progression [patf]
GIVEN [cnce]
Combination [qlco]
Whole-Brain Radiotherapy [topp]
randomized [resa]
Phase III Study [resa]
Pre-clinical [qlco]
Suggest [idcn]
Drug [phsu]
Enhance [acty]
Antineoplastic [orch, phsu]
effects [qlco]
Chemotherapy [topp]
Methods [inpr]
Arm [blor]
OPEN LABEL [resa]
Phase 1 [tmco]
Dose [qnco]
Study [mnob]
Administered [ftcn]
docetaxel [orch, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
Cisplatin [inch, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
motexafin gadolinium [irda, orch, phsu]
3 Weeks [tmco]
Patients [podg]
Metastatic [ftcn]
Non-Small Cell Lung Cancer [neop]
twenty [orch, phsu]
Patients [podg]
treated [topp]
Dose Level [qnco]
Maximal Tolerated Dose [qnco]
mg kg [qnco]
Cycle [tmco]
Dose-Limiting [idcn]
toxicities [inpo]
Febrile Neutropenia [dsyn]
Hypertension [dsyn]
myocardial ischaemia [dsyn]
Pneumonitis/pulmonary infiltrates [fndg]
Grade 4 [qlco]
adverse events [fndg]
cohorts [popg]
APPEAR [qlco]
Exacerbated [fndg]
included [ftcn]
Granulocytopenia [dsyn]
Fatigue [sosy]
Dehydration [dsyn]
Nausea [sosy]
Vomiting [sosy]
Episodes [tmco]
myocardial ischaemia [dsyn]
Sudden death [patf]
Unknown [qlco]
Observed [ftcn]
Response Rate [tmco]
partial response [fndg]
Stable Disease [fndg]
Disease Progression [patf]
Conclusions [idcn]
Regimen [topp]
Study [mnob]
TOLERABILITY [resa]
activity [dora]
Patients [podg]
Metastatic [ftcn]
Non-Small Cell Lung Cancer [neop]
Recommended [idcn]
Dose [qnco]
Future [tmco]
Phase [tmco]
Trial [resa]
motexafin gadolinium [irda, orch, phsu]
mg kg [qnco]
docetaxel [orch, phsu]
M NOS [aapp, imft]
Cisplatin [inch, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
3 Weeks [tmco]
Patients [podg]
History [ocdi]
Cardiovascular disease [dsyn]
